HansBiomed Corporation (KOSDAQ:042520)

HansBiomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	691,588	235,973	127,792	207,570	92,964	160,691
Market Cap Growth	522.84%	84.65%	-38.43%	123.28%	-42.15%	-29.01%
Enterprise Value	718,826	268,360	153,787	241,607	132,643	187,080
Last Close Price	50400.00	18170.00	9840.00	17930.00	9610.00	16050.00
PE Ratio	-	-	-	-	15.12	-
Forward PE	-	6.95	6.95	6.95	6.95	6.95
PS Ratio	6.90	2.63	1.58	2.66	1.25	2.72
PB Ratio	9.75	6.96	1.90	4.16	1.96	3.38
P/TBV Ratio	9.82	7.11	1.93	4.29	2.08	3.70
P/OCF Ratio	-	741.27	72.67	-	-	-
EV/Sales Ratio	7.18	2.99	1.90	3.10	1.78	3.17
EV/EBITDA Ratio	-	-	25.58	231.57	21.54	-
EV/EBIT Ratio	-	-	245.82	-	105.60	-
EV/FCF Ratio	-27.81	-	-	-	-	-
Debt / Equity Ratio	0.61	1.28	0.54	0.82	1.18	1.08
Debt / EBITDA Ratio	-	-	6.06	39.43	9.08	-
Net Debt / Equity Ratio	0.38	1.04	0.44	0.68	0.89	0.66
Net Debt / EBITDA Ratio	-1.34	-1.54	4.85	32.68	6.88	-2.09
Net Debt / FCF Ratio	-1.05	-22.77	-34.90	-6.01	-5.13	-1.60
Asset Turnover	0.77	0.72	0.67	0.61	0.57	0.45
Inventory Turnover	1.39	1.34	1.05	1.20	1.26	1.64
Quick Ratio	0.60	0.31	0.38	0.31	0.32	0.49
Current Ratio	1.16	0.69	0.99	0.77	0.73	0.84
Return on Equity (ROE)	-41.69%	-63.51%	-13.33%	-49.47%	10.36%	-37.86%
Return on Assets (ROA)	-12.16%	-14.05%	0.32%	-2.04%	0.60%	-9.46%
Return on Invested Capital (ROIC)	-30.27%	-33.74%	0.69%	-4.78%	1.49%	-25.01%
Return on Capital Employed (ROCE)	-31.50%	-61.50%	0.90%	-7.30%	2.20%	-28.90%
Earnings Yield	-3.97%	-13.28%	-5.65%	-11.10%	6.61%	-11.38%
FCF Yield	-3.74%	-0.65%	-0.65%	-2.73%	-8.88%	-12.16%
Buyback Yield / Dilution	-0.90%	-0.29%	-20.83%	18.41%	-31.21%	-1.48%
Total Shareholder Return	-0.90%	-0.29%	-20.83%	18.41%	-31.21%	-1.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.